CSL BEHRING GENE THERAPY, INC. – Trademark Portfolio
Entity Type: 03
CSL BEHRING GENE THERAPY, INC. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 6 Nice Classification classes. Currently, 0 trademarks are registered and 5 are pending. The owner is based in TUSCON, AZ.
5151 E. BROADWAY BOULEVARD
SUITE 700
TUSCON, AZ 85711
Showing of trademarks Trademarks
Trademark Classifications
CSL BEHRING GENE THERAPY, INC.'s trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does CSL BEHRING GENE THERAPY, INC. have?
CSL BEHRING GENE THERAPY, INC. has 8 U.S. trademarks filed with the USPTO. Of these, 5 pending, 1 abandoned, 2 cancelled.
What trademark classes does CSL BEHRING GENE THERAPY, INC. file in?
CSL BEHRING GENE THERAPY, INC. files trademarks across 6 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 40 (Treatment & Processing), Class 35 (Advertising & Business), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What is CSL BEHRING GENE THERAPY, INC.'s trademark registration success rate?
CSL BEHRING GENE THERAPY, INC. has a 0% trademark registration rate, with 0 out of 3 resolved applications resulting in successful registration. Currently, 5 applications are pending review.